Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Ahmed Z. Obeidat"'
Autor:
Isabella Gomez Hjerthen, Cristina Trápaga Hacker, William Meador, Ahmed Z. Obeidat, Lucas Horta, Farrah J. Mateen
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 4, Pp 1011-1020 (2024)
Abstract Background and Objectives We aim to characterize the sociodemographic and clinical factors associated with loss of jobs, income, and work hours in people with neuromyelitis optica spectrum disorder (NMOSD) in the United States. Methods A RED
Externí odkaz:
https://doaj.org/article/52e2c86ffd5e4720bf379968148c671c
Publikováno v:
Biomarkers in Neuropsychiatry, Vol 9, Iss , Pp 100077- (2023)
Cognitive Impairment (CI) is one of the most common and devastating manifestations in patients with Multiple Sclerosis (MS), which directly impacts the quality of life (QOL) and increases the burden of the disease. Years ago, CI was underrated but re
Externí odkaz:
https://doaj.org/article/c1507f3524f344f6adf64569db6c945f
Publikováno v:
Journal of NeuroEngineering and Rehabilitation, Vol 19, Iss 1, Pp 1-16 (2022)
Abstract Background People with multiple sclerosis (PwMS) have balance deficits while ambulating through environments that contain moving objects or visual manipulations to perceived self-motion. However, their ability to parse object from self-movem
Externí odkaz:
https://doaj.org/article/cab5cdabc0084e5098e3dbf1207c108b
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/e785e476a80d4b0b9e411a3faf899a44
Publikováno v:
Journal of Central Nervous System Disease, Vol 14 (2022)
Externí odkaz:
https://doaj.org/article/e543aad829a04ca8a19af904946ce4d7
Publikováno v:
Journal of Central Nervous System Disease, Vol 14 (2022)
BACKGROUND There is currently limited literature addressing the reporting of alopecia in multiple sclerosis (MS) patients treated with disease-modifying therapies (DMTs). Anecdotal reports of hair thinning from patients on various DMTs prompted furth
Externí odkaz:
https://doaj.org/article/dd2b4f341e554151809697e09743a493
Autor:
Mitra Rouhani, Sandra Hunter, Marie K. Hoeger Bement, Ahmed Z. Obeidat, Kathleen M. Zackowski, Alexander V. Ng
Publikováno v:
Multiple Sclerosis and Related Disorders. 73:104646
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5eeed6b99339977dcd9a6dc641684c7
https://doi.org/10.1016/j.msard.2023.104646
https://doi.org/10.1016/j.msard.2023.104646
Autor:
Myla D. Goldman, Douglas Jeffery, Jeff F. Dunn, Le H. Hua, Erin E. Longbrake, Sarah Hopkins, Jeffrey M. Gelfand, Ahmed Z. Obeidat, Kathleen Costello, Jeffrey A. Cohen, Vijayshree Yadav, Scott D. Newsome, Suma Shah, Stephen Krieger, Nancy L. Sicotte, Lilyana Amezcua
Publikováno v:
Neurol Clin Pract
Management of multiple sclerosis and neuroimmunologic disorders has become increasingly complex because of the expanding number of recognized neuroimmune disorders, increased number of therapeutic options, and multidisciplinary care management needs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6c6fcf472ac18a6f83b313dd3cb59f9
https://doi.org/10.1212/cpj.0000000000001040
https://doi.org/10.1212/cpj.0000000000001040
Autor:
Jeri Burtchell, Daisy Clemmons, Joann Clemmons, Tim Sabutis, Adeline Rosenberg, Jennifer Graves, Michael L. Sweeney, John Kramer, Marina Ziehn, Brandon Brown, Jamie L. Weiss, Ahmed Z. Obeidat
Publikováno v:
Neurology and therapy. 11(3)
The mechanisms of action of disease-modifying therapies (DMTs) for multiple sclerosis (MS) are complex and involve an interplay of immune system components. People with MS (PwMS) may lack a clear understanding of the immunological pathways involved i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1e17742fea3d4d24f552e09d3866e88
https://pubmed.ncbi.nlm.nih.gov/35608740
https://pubmed.ncbi.nlm.nih.gov/35608740
Publikováno v:
Multiple Sclerosis and Related Disorders. 63:103832
Some pathways involved in the pathogenesis of psoriasis share similarities with processes involved in multiple sclerosis (MS) pathogenesis. However, the association between MS and psoriasis is poorly understood. Since disease-modifying therapies for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0355cf01b20c95aa5c08242b20e14998
https://doi.org/10.1016/j.msard.2022.103832
https://doi.org/10.1016/j.msard.2022.103832